ask="11.30"
ask_size="300"
average_daily_volume="220232"
bid="9.90"
bid_size="500"
book_value="2.66"
change="-0.28"
change_from_200_day_moving_average="1.64"
change_from_50_day_moving_average="0.97"
change_from_52_week_high="-0.88"
change_From_52_week_low="3.19"
change_in_percent="-2.67%"
close="10.19"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.30"
ebitda="-117.58M"
eps_estimate_current_year="-2.04"
eps_estimate_next_quarter="-0.58"
eps_estimate_next_year="-1.71"
ex_dividend_date="N/A"
float_shares="15522000"
high="10.45"
high_52_weeks="11.07"
last_trade_date="1/11/2017"
last_trade_price="10.19"
last_trade_size="10673"
last_trade_time="4:00pm"
low="9.90"
low_52_weeks="7.00"
market_capitalization="186.48M"
moving_average_200_day="8.55"
moving_average_50_day="9.22"
name="Akebia Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.00"
open="10.29"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+19.18%"
percent_change_from_50_day_moving_average="+10.47%"
percent_change_from_52_week_high="-7.95%"
percent_change_from_52_week_low="+45.57%"
previous_close="10.47"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.94"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18300000"
short_ratio="13.24"
stock_exchange="NGM"
symbol="AKBA"
volume="367169"
weeks_range_52="7.00 - 11.07"
